RLX Technology Inc. (NYSE: RLX) saw its stock surge 7.73% in pre-market trading on Friday, following the release of its impressive third-quarter 2025 financial results. The company reported a significant 49.3% year-over-year increase in net revenues, reaching RMB 1.13 billion (US$158.6 million) for Q3 2025, exceeding analyst expectations.

The strong performance was primarily driven by successful international expansion efforts, particularly in Asia Pacific and European markets. RLX Technology's gross margin improved to 31.2% from 27.2% in the same period last year, while non-GAAP net income rose to RMB 295.4 million (US$41.5 million), representing a 12.1% year-over-year increase. The company also benefited from an improved regulatory environment in Mainland China, which fostered a more orderly and compliant competitive landscape, supporting the steady recovery of their business in the region.

Further boosting investor confidence, RLX Technology announced a cash dividend of US$0.1 per American Depositary Share (ADS), underscoring its commitment to returning value to shareholders. The company's successful launch of a proprietary modern-oral product line in the UK and its continued focus on R&D innovation have positioned it well for future growth in the global e-vapor market.